Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study

Author： Hadji Peyman   Kauka Annette   Ziller May   Birkholz Katrin   Baier Monika   Muth Mathias   Kann Peter  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.144, Iss.2, 2014-04, pp. : 343-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adjuvant endocrine therapy in premenopausal women with breast cancer

By González Martín Antonio   Cruz Susana   Márquez Raúl  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-09 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment

By Niikura Naoki  

Breast Cancer, Vol. 20, Iss. 1, 2013-01 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

By Sverrisdottir Asgerdur  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 755-763

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

By Jakesz R.   Hausmaninger H.   Samonigg H.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

By Cameron David   Douglas Sharon   Brown Janet   Anderson Richard  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 805-814

Springer Publishing Company

Access to resources Recommend Favorite